PerspectivesNew currents
February 14, 2023
Mineralys Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Read More
February 9, 2023 Mineralys Therapeutics Announces Pricing of Upsized Initial Public Offering
RADNOR, Pa., Feb. 09, 2023 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven …
Continue reading “Mineralys Therapeutics Announces Pricing of Upsized Initial Public Offering”

March 28, 2022 Aculys Pharma Closes US$24 Million Series B Financing
Aculys Pharma, Inc. (“Aculys Pharma” Headquarters: Fujisawa City, Kanagawa Prefecture, Representative Director and CEO: Kazunari Tsunaba), a new biopharmaceutical company focused on the development and …
Continue reading “Aculys Pharma Closes US$24 Million Series B Financing”

March 10, 2022 Catalys Pacific Calls for Economical Disengagement from Russian Industry
Catalys Pacific would like to inform that we have signed onto an open letter to call for the global business community to economically disengage from …
Continue reading “Catalys Pacific Calls for Economical Disengagement from Russian Industry”

February 17, 2022 Catalys Pacific Adds Experienced Pharmaceutical Executive to Life Sciences Team
Tokyo, Japan Catalys Pacific announced that Mr. Neal Fowler has joined the team at Catalys Pacific as Operating Partner. Neal has extensive experience in biotech/biopharma …
Continue reading “Catalys Pacific Adds Experienced Pharmaceutical Executive to Life Sciences Team”

October 4, 2021 Catalys Pacific Strengthens Company Creation Team with New Operating Partner
Catalys Pacific announced that Mr. Kazunari Tsunaba has joined the team at Catalys Pacific as Operating Partner. Kaz will contribute to our inbound strategy to …
Continue reading “Catalys Pacific Strengthens Company Creation Team with New Operating Partner”

April 6, 2021 Mineralys Therapeutics Closes $40 Million Series A Funding
PHILADELPHIA, PA, April 6, 2021 — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific, announced today that the Company completed a …
Continue reading “Mineralys Therapeutics Closes $40 Million Series A Funding”

November 4, 2020 Catalys Pacific Strengthens Company Creation Team with New Operating Partner
Tokyo, Japan – November 4, 2020 Catalys Pacific announced that Mr. Jay Shepard has joined the team at Catalys Pacific as Operating Partner. He will …
Continue reading “Catalys Pacific Strengthens Company Creation Team with New Operating Partner”

June 19, 2020 Catalys Pacific Strengthens Company Creation Team with New Industry Advisor
Tokyo, Japan – June 19, 2020 Catalys Pacific announced that Dr. Nobuo Hanai has joined the team at Catalys Pacific as Industry Advisor. He will …
Continue reading “Catalys Pacific Strengthens Company Creation Team with New Industry Advisor”